Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BELLUS Health Inc. - Common Shares (NQ: BLU )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 14.73 (50)
Ask (Size) 14.75 (36)
Prev. Close 14.74
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 55,378,660
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs
Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as... 
Via Benzinga
BELLUS Health Inc. Announces Voting Results from Special Meeting of Shareholders
From BELLUS Health Inc.
Via Business Wire

Performance

More News

Read More
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
Via Investor's Business Daily
BELLUS Health: Q1 Earnings Insights
Via Benzinga
GSK Stock: A Value Trap or a Hidden Gem?
Via InvestorPlace
BELLUS Health Inc. Calls Special Shareholders’ Meeting in Connection with GSK Acquisition
From BELLUS Health Inc.
Via Business Wire
BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights
From BELLUS Health Inc.
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruth’s Inc. (Nasdaq – RUTH), Magenta Therapeutics, Inc. (Nasdaq – MGTA), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX)
From Brodsky & Smith LLC
Via GlobeNewswire
Where BELLUS Health Stands With Analysts
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq – SPPI), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX), Univar Solutions Inc. (NYSE - UNVR)
From Brodsky & Smith LLC
Via GlobeNewswire
BELLUS Health Announces Meeting Updates
From BELLUS Health Inc.
Via Business Wire
BELLUS Health Inc. (NASDAQ: BLU) Leading the Way in Tuesday Trading Based on Percentage Gain
Via Investor Brand Network
3 Biotechs That Might Get Bought Out in 2023
Via The Motley Fool
Was This Acquisition a Savvy Play by This Big Pharma Stock?
Via The Motley Fool
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq – SPPI), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX), Univar Solutions Inc. (NYSE – UNVR)
From Brodsky & Smith LLC
Via GlobeNewswire
Second Quarter Outlook For Biotech Stocks
Via Talk Markets
Why This Nasdaq Stock Caught Fire This Week
Via The Motley Fool
Why Shares of Bellus Health Skyrocketed This Week
Via The Motley Fool
Dow Edges Higher; Goldman Sachs Posts Upbeat Earnings
Via Benzinga
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health
From BELLUS Health Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2023
Via Benzinga
Dow Dips Over 100 Points; Bank of America Earnings Beat Estimates
Via Benzinga
Why BELLUS Health Stock Is Rocketing Higher Today
Via The Motley Fool
Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2023
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.